Yimu Zhao, Ph.D. is a postdoctoral research scientist at Columbia University’s Department of Biomedical Engineering in New York City, under the guidance of Dr. Gordana Vunjak-Novakovic. Her primary research interest is to develop integrated multi-hierarchical vasculature with parenchymal tissues that recapitulates organ-specific phenotypes and functional maturations. She also investigates the approaches to connect multiple organ-specific vascular network to study drug testing and disease phenotypes across multiple tissue types.
She received her Ph.D. in 2019 under the supervision of Dr. Milica Radisic at University of Toronto. During her Ph.D., she designed and developed the Biowire II Organ-on-a-Chip platform, a drug inert tissue culture and testing platform that employs super-elastic biomaterials as biosensors and culture 3D adult-like cardiac tissue arrays. The technology combines technologies in developmental biology, tissue engineering, and microfluidics, and enables 1) the culture of multiple tissue models, including adult-like chamber-specific healthy and patient-specific diseased cardiac tissues. 2) compatibility with the pharmaceutical industrial practice and 3) multiple cardiac functional readouts through material-based biosensors. She is one of the inventors of TARA’s BiowireTM platform technology (Patent) and is one of the co-founders of TARA. She has published in Cell, Advanced Healthcare Materials,
She obtained her B.A.Sc. (Chemical Engineering) from University of Western Ontario and M.A.Sc. (Chemical Engineering) from Queen’s University, Ontario, Canada. There she worked on stem cell technology in the laboratory of Dr. Lauren Flynn and Dr. Stephen Waldman for multi-lineage differentiation and application of adipose-derived stem cells.